Prevalence of muscular dystrophy in patients with muscular disorders in Tehran, Iran
Submitted: 27 February 2018
Accepted: 7 April 2018
Published: 18 May 2018
Accepted: 7 April 2018
Abstract Views: 1178
PDF: 608
HTML: 167
HTML: 167
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Paola Arslan, Barbara Ravara, Implementing EjtM3 (European Journal of Translational Myology, Mobility, Medicine) along the silk-road , European Journal of Translational Myology: Vol. 28 No. 2 (2018)
- The Editors, Abstracts of the 2017 Spring Padua Muscle Days: Translational Myology for Impaired Mobility | Euganei Hills, Padua, Italy, March 23-25, 2017 , European Journal of Translational Myology: Vol. 27 No. 2 (2017)
- Ugo Carraro, EJTM3 is also covering Mobility and Medicine at large, an update , European Journal of Translational Myology: Vol. 28 No. 3 (2018)
You may also start an advanced similarity search for this article.